Catalyst Wire Dossier Catalyst Wire Dossier
FDA guidance ·

FDA Takes Step Forward on Testosterone Therapy for Men

View source ↗

Summary

FDA indicates interest in exploring potential new indication for testosterone replacement products to treat low libido in men with idiopathic hypogonadism and i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

FDA is taking an initial step to advance treatment options for men’s health by encouraging sponsors of approved testosterone replacement therapy products to contact FDA for information if they are interested in pursuing a potential new indication for low libido in men with idiopathic hypogonadism.